PET scanning in head and neck oncology: a review.

Pet scanning in head and neck oncology: A review


Background The objective of this study was to review and describe the usage of fluorine-labeled deoxyglucose (FDG) and positron emission tomography (PET) in the diagnosis and management of head

Pet scanning in head and neck oncology: A review – McGuirt


Positron emission tomography scanning using a fluorine-labeled deoxyglucose (FDG) radiotracer proved as reliable as conventional scanning for primary and metastatic tumor identification. Compared with clinical examination, PET was better for identification of nodal metastatic tumors but …

PET-CT Surveillance versus Neck Dissection in Advanced


Review Article Classification, Ontology, Gupta T, Master Z, Kannan S, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review

Timing of Post-TX Imaging Key in Head, Neck Cancer – Medscape

Diagnostic Performance of Post-treatment FDG PET or FDG PET/CT Imaging in Head and Neck Cancer: a Systematic Review and Meta-analysis Gupta T, Master Z, Kannan S, et al Eur J Nucl Med Mol Imaging


PET Imaging in Head and Neck Cancer Patients to Monitor

Review PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging Laura K.van Dijk1,2, Otto C. Boerman2, Johannes H.A.M. Kaanders1, and Johan Bussink1 Abstract

PET-CT–Guided Surveillance of Head and Neck Cancers

The prospective randomized controlled PET-NECK Trial was launched to determine the clinical usefulness and cost-effectiveness of planned neck dissection versus PET-CT–guided surveillance in patients with advanced squamous cell carcinoma of the head and neck.

The Lack of Evidence for PET or PET – PubMed Central (PMC)


Methods. We searched MEDLINE and Cochrane Library databases from 1996 to March 2012 for relevant English-language studies of PET or PET-CT used for surveillance in patients with lymphoma, colorectal cancer, or head and neck cancer.


Clinical Utility of FDG-PET for Head and Neck CA

(Detection of Known Primary Head and Neck Cancer) False Negative PET’s for HNC are usually due to very small tumors • Review Article by Schoder/Yeung • 11 studies, 300 patients. • PET scan detects distant metastases in head and neck CA as well: • Fleming, Laryngoscope, 2007: 15%

PET/CT in head and neck oncology: State-of-the-art 2013


PET/CT is highly sensitive in staging of patients with squamous cancer of the head and neck. The sensitivity is limited by tumor size, and PET/CT cannot currently replace the information obtained from elective neck dissection in the assessment of cervical metastases.

Veröffentlicht in:Laryngoscope · 2014Autoren:Jonas T Johnson · Barton F BranstetterZugehörigkeit: University of PittsburghÜber:PET-CT

FDG-PET/CT pitfalls in oncological head and neck imaging

Objectives. Positron emission tomography-computed tomography (PET/CT) with fluorine-18-fluorodeoxy-D-glucose (FDG) has evolved from a research modality to an invaluable tool in head and neck cancer imaging.